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Drugs ot Abuse

Fentanyl: Abuse Potential and Prevention Strategies for Pharmacists
Margaret Rowland, fourth-year pharmacy student from Boardman, Ohio, Amanda Hoersten, fourth-year pharmacy student from Delphos, Ohio,
Sarah Webb, firth-year pharmacy student from Mt. Gilead, Ohio; H. Paige Stewart, fifth-year pharmacy student from Centerburg, Oho. Lindsey Hallman, fifth-year pharmacy student from North Royalton, Ohio; Michael Milks, BSPh 76, Ph.D., R.Ph, professor of pharmacology
Abstract
The abuse of fentanyl is becomirg more prevalent, with patients devising new methods of extraction morder to abuse it. Fentanyl patches
were originally intended for the opioid tolerant patients still requiring
pain relief, but illicit use and drug diversion of this medication continues
to grow at an alarming rate. Several cases of abuse have been documented in which patients were chewing patches for oral absorption,
d1stillmg the drug mto hquld form tor 1njection, or rectally inserting the
patches. To dLSCOurage and prevent abuse, a keenly aware pharmac1S1
can provide pa tie ms with 1m JXlrlant counseling points on properuse,
disposal and educaoon about fertanyl 11Self.
Background
Fentanyl patches are prescnbed for the treatment of persistent, moderate-to-severe chronic pain. This drug therapy is reserved for patients
who are opioid tolerant; however, due to its euphoria-inducing properties, fentanyl has a high JX)tential for abuse. While fentanyl is less commonly abused than medications such as oxycodone or hydrocodone,
abuse has increased in the last decade, with widespread epidemics
occurring in cities such as Chicago, Detroit and Philadelphia.24 In 2006,
fentanyl was the fifth most common cause of emergency department
visits resulting from nonmedical prescription narcotic analgesics.5 Due to
the prevalence of abuse and severe consequences of misuse, there is
a definite need for intervention and patient education on the safe use of
transdermal patches.
Fentanyl acts systemically as a mu-opioid receptor agomst (table 1)
and has the capability to cross the blood-brain barrier due to its highly
liJXlphilic nature, which results in analgesic effects, mood alterations,
euphoria, dysphona and drowsmess. 1The high potency of fentanyl
allows for a therapeutic dose to be applied to a relatively small area of
skin. Chrome opioid users frequently develop tolerance to the analgesic
and euphoric effects, but not to the respiratory depressive effects. Toxicity can range from mild, which presents with drowsiness and headache,
to severe which may result in respiratory arrest, hypotension and even
death. Adverse effects of the transdermal application include nausea,
vomiting, confusion, skin irritation and insomnia.
Table 1: Systemic effects ol tentanyl by opioid receptor type'
Opioid receptor Systemic ettects
Mu
Sui:raspnal ard ~ripheral analgesia, sedation, ard
euprona

Kappi

Spinal analgesa, respiratory depression, physical
de~rdenoe, GI dysmotllity, bradycardia, pruntus
Spnal analgesa ard m10Sis
Oysprona and i:sychotomimesis
Sup-aspnal aralges1a
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As an alt!:!1npl lo <.M!:!1 abuSI:!, a novel 111atrix deliv!:!1y system was 11101e
recently introduced.6 The new patch is smaller, with fentanyl-containing
dipropylene glycol droplets incorporated into the adhesive rather than the
original reservoir system , which is known to leak drug and allows for simple
drug extraction. The matrix delivery system has a rate-controlling membrane to improve drug release, which allows the amount of drug loaded in
the patch to be reduced by almost 35 percent compared to that contained
in the original reservoir system. Since fentany is completely dissolved in a
semisolid state in the matrix formulation, the risk of incidental drug leakage
1s decreased. Extraction of drug for abuse was thought to be more difficult,
though it has now been shown to be iust as commonly abused as the
original reservoir patches. 7
Methods of Abuse
Abuse of transdermal fentanyl patches involves unintended routes of
admin1Stration achieved by altering the delivery system In s1tuatons of
abuse, fentanyl may be introduced by transmucosal applicatJon, ingestion,
intravenous mpction of the patch contents , volaohzaoon and inhalallon,
application of heat to a transdermal patch, or rectal insertion.8' While the
patches are intended for slow, steady drug release, these rapid infusion
methods result in uncontrolled quantities of drug delivered.3 Moreover, fentanyl is frequently abused in conjunction with alcohol or other illicit drugs,
even acting as a substitute for heroin. 9
The most JXlpular method of abuse involves placement of a transdermal fentanyl patch inside the oral cavity.8.9 Oral abusers will affix a patch, or patches,
on the buccal membrane, chewon the patch, or boil the patch and consume
the liquid. Being thin and lacking kerabmzatJon, the buccal membrane allows
for rapid absorption, making this an appealing route for abusers. Chewing the
patch is particularly dangerous due to the mechanical disrupton of the patch,
causing release of more than 72 hours worth ol drug at one bme. Liappas
reJX)rted a case in which a 36-year-old woman was prescnbed 25 mcg/hr
fentanyl patches, three times daily.10 Believing the drug was not appropriately
penetrabng her skin and providing her with adequate relief, the patient began
to apply the patches to the oral cavity. The woman claimed she was able to
achieve faster, more effective pain relief using this route. Over the course of
several months, the patient increased the dose from 75 mcg/hr daily to 250
mcglhrdaily, totaling 10 patches, which she continued for 15 months. Due
to her long-term abuse, the patient developed a high tolerance along with a
strong dependence on fentanyl.
Street drug users also have been found misusing fentanyl patches, specifically,

the newer matrix formulation.7 Users are able to easily retrieve fentanyl by
adding vinegar and water to the patch and alklwilg it to soak or by heating the
patch. The resulting solution is placed in a container, from wh.:h users load a
synnge and inpct the drug intravenously. In add1110n to the increased risk of disease transmission, rt is difficult to assess the JX)tency of the drug because the
quantity and time-released formulation make rt impossible to know the amount
of drug being 1nj3cted. This presenlS a high nsk of accidental overoose.
One of the less frequent, yet more dangerous, routes of administration is
rectal insertion of the transderrnal patch. 9 Similar to the buccal membrane,
the rectal mucosa is non-keratinized, which, combined with the elevated
Mardl 2011

Fentanyl: Abuse Potential and Prevention Strategies for Pharmacists
temperature, facilitates rapid absorption of fentanyl. In a case reported
by Coon, a man was brought into :he emergency room , unconscious
after rectally insemng three 100 rncg/hr transdermal fentanyl patches.
Upon adm1Sst0n, he was given 6 mg of naloxone, to which he did not
respond, and was subsequently intubated. An hour after removal of the
patches, the patient finally awoke. Acu te onset of coma was attributed to
elevation of serum fentanyl levels faster than usual, a direct result of the
combination of the rapid absorption and number of high-dose patches
inserted. The authors suggest that, in such cases , aggressive digital rectal examination, combined with anoscopy orsigmoidoscopy, should be
utilized to ensure all internalized patches are recognized and removed.
A number of tactics are employed by potential fentanyl abusers in order
to acquire the transdermal patches.3•10 Methods include obtaining multiple
prescriptions from more than one health care provider, illegal purchase
from a drug dealer, theft from a patient who has a legitimate prescription,
and removal from the trash or off of a person wearing a patch, including
patients in a hospital or morgue.
Prevention and Treatment: The Role of Health Care Professionals
Several methods of monitonng pa:ients who have been prescribed
transdermal fentanyl have been proposed. 10 The mapr focus should
be on the initial prevention of abuse, which could include requinng the
original prescnption and all follow-ups be conducted through specialized
pain centers. Anticipation of drug-abuse potential and identtfication of
populations at greater risk of abuse should be considered. Importance
is also placed on recognition of abuse behavior and predisposrtion by
thorough examination, including both family and social history of the
prospective patient Any signs of abuse or dependence should be identified and adequately addressed before a prescription is issued. Signs of
opiate withdrawal include anxiety,enlarged pupils, excessive sweating,
or an increase in blood pressure , pulse and temperature. To monrtor
for patient compliance and illicit drug use, urine and blood screenings
should be encouraged. For those n which abuse of fentanyl has been
identified , effective treatment may be most beneficially provided through
facilities employing specifically tra ned psychologists or psychiatrists who
can offer psychotherapeut1C therapy to complement any required medical treatment. Conslderaoons should be made to taper the patient off the
drug in order to avoid withdrawal symptoms. Adding a weak opioid, such
as codeine, to the therapy regimen can further facilitate this process.
Pharmacist Counseling Points
Due to its dangerous adverse effects, patients should be fully educated al:xlut
the abuse potential, tife-threatening dangers and proper disposal of fentanyl
patches. 11 Pharmacists should consoor a few points when counseling a patient
A medication guide must be provided with each dispensing.
Patches are intended for transdermal use on intact skin only.
Instruct patients not to use a patch if the package is broken or the
patch is cut, damaged or altered.
Avoid exposure of the application site to any external heating source 00cause
drug release may be increased, wtich could lead to overdose or death.
Keep patches in a secure locatlon away from pets, children and
potenoal theft of the med1cat1on.
• Fentanyl's high potency and significant amount of drug remaining m
used parches have resulted 1n manufacturer and FDA guidelines stating to fold the patch upon itself and immediately flush both used and
leftover patches down the toilet.
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Pharmacists need to be alerted to drug-seeking behaviors, including
urgent refill requests or visits near the end of operating hours, "losr
prescnptions, altered prescriptions, and refusal or reluctance to disclose
other medications or current phys1c1an(s). A common tacoc among abusers IS "doctor shopping" to obtain additional prescnptJons and "pharmacy
hopping" to fill multiple prescriptions for controlled substances.
Conclusion
With recent reports of transdermal fentanyl abuse on the rise, it is critical
that pharmacists take an active role in preventing further perpetuation
of abuse. This can be accomplished by awareness of the incidence
and methods employed by abusers , including altering the patch or use
via unintended routes of administration. Patients who have a legitimate
need for this medication require proper education and monitoring to
avoid abuse or accidental overdose or drug diversion. Health care professionals should be aware of signs and symptoms of abuse and proper
treatment methods. Due to the highly potent nature and deadly adverse
reactions associated with fentanyl, its misuse should nor be taken lightly.
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